Faculty Publications

As of August 2017, this database is no longer being updated. For the most current publications from the faculty, students, and staff of Touro University, please check our institutional repository, Touro Scholar, and email any questions or publication submissions to touro.scholar@touro.edu.

Total number of publications: 7,082

Enter a faculty name:

Administrative Offices

Graduate Schools

Health Sciences

Lander Colleges

Law Center

New York School of Career and Applied Studies (NYSCAS)

Touro University System

First Prev 1 2 3 4 5 6 7 8 9 10 Next Last
  • Brixner, D. I., Bron, M., Bellows, B. K., Ye, X., Yu, J., Raparla, S., & Oderda, G. M. (2013). Evaluation of cardiovascular risk factors, events, and costs across four BMI categories. Obesity, 21(6), 1284-1292.  doi:10.1002/oby.20215

  • Brooks, R., Goldberger, J. J., & Kadish, A. H. (1993). Extended protocol for demonstration of dual AV nodal physiology. Pacing and Clinical Electrophysiology, 16(2), 277-284. This material can be found here.

  • Burke, J., Ehlert, F. A., Kruse, J., Parker, M., Goldberger, J. J., & Kadish, A. H. (1993). Gender differences in sinus cycle length before and after autonomic blockade: Are they truly gender related? Circulation88(4), I-45.

  • Burke, J., Ehlert, F., Kruse, J., Goldberger, J. J., & Kadish, A. H. (1994). Menstrual cycle variability in the QTc interval. Circulation90, I-663.

  • Burke, J. H., Goldberger, J. J., Ehlert, F. A., Kruse, J. T., Parker, M. A., & Kadish, A. H. (1996). Gender differences in heart rate before and after autonomic blockade: Evidence against an intrinsic gender effect. American Journal of Medicine, 100(5), 537-543. doi:10.1016/S0002-9343(96)00018-6

  • Challapalli, S., Lingamneni, R., Ehlert, F., Goldberger, J. J., & Kadish, A. H. (1997). Gender differences in QT dispersion [Supplemental material]. Journal of the American College of Cardiology, 29(S1), 148A. doi:10.1016/S0735-1097(97)86227-4

  • Challapalli, S., Lingamneni, R., Horvath, G., Parker, M., Goldberger, J. J., & Kadish, A. H. (1998). Twelve-lead QT dispersion is smaller in women than in men. Annals of Noninvasive Electrocardiology, 3(1), 25-31. doi:10.1111/j.1542-474X.1998.tb00026.x

  • Chang, T., & Sadik, A. (2013). Maté's ability to protect cardiomyocytes from oxidative stress. Journal of the American College of Nutrition, 32(5), 363. See corrigendum here.

  • Chen, R. F., Kushner, J. A., Toivonen, L. K., Morady, F., Kadish, A. H. (1988). Beta blocking effects of amiodarone. Circulation, 78, II-499.

  • Chi, H., Messas, E., Levine, R. A., Graves, D. T., & Amar, S. (2004). Interleukin-1 receptor signaling mediates atherosclerosis associated with bacterial exposure and/or a high-fat diet in a murine apolipoprotein E heterozygote model: Pharmacotherapeutic implications. Circulation, 110(12), 1678-1685. doi:10.1161/01.CIR.0000142085.39015.31

  • Clearfield, M. B. (2011, April). Cardiovascular benefits of aggressive cholesterol-lowering therapy. Journal of the American Osteopathic Association, 111(4 Suppl. 3), i-eS2.

  • Clearfield, M. B. (2011). Combination lipid therapy in type 2 diabetes. Current Atherosclerosis Reports, 13(1), 1-3. doi:10.1007/s11883-010-0139-y

  • Clearfield, M. B. (2011). Statins in combination: From ARBITER-6 HALTS to ACCORD. What works? Current Atherosclerosis Reports, 13(1), 4-8. doi:10.1007/s11883-010-0142-3

  • Clearfield, M. B. [Contributor for Cholesterol Treatment Trialists' (CTT) Collaboration]. (2012). Lack of effect of lowering LDL cholesterol on cancer: Meta-analysis of individual data from 175,000 people in 27 randomised trials of statin. PLos One, 71(1) [Article e29849]. doi:10.1371/journal.pone.0029849

  • Clearfield, M. B. [Contributor for Cholesterol Treatment Trialists' (CTT) Collaboration]. (2012). The effects of lowering LDL-C with statin therapy in people at low risk of vascular disease: A meta-analysis of individual data from 27 randomized trials. The Lancet, 380(9841), 581-590. PMCID: PMC3437972

  • Clearfield, M. B., Pearce, M., Nibbe, Y., Crotty, D., & Wagner, A. (2014). The "new deadly quartet" for cardiovascular disease in the 21st century: Obesity, metabolic syndrome, inflammation and climate change: How does statin therapy fit into this equation? Current Atherosclerosis Reports, 16(1) [Article 380]. doi:10.1007/s11883-013-0380-2

  • Cusnir, H., Tongia, R., Sheka, K. P., Kavesteen, D., Segal, R. R., Nowakiwskyj, V. N., . . . Yens, D. P. (2004). In hospital cardiac arrest: A role for automatic defibrillation. Resuscitation, 63(2), 183-188. doi:10.1016/j.resuscitation.2004.05.012

  • Dager, W. E., Gosselin, R. C., & Roberts, A. J. (2013). Reversing dabigatran in life-threatening bleeding occurring during cardiac ablation with factor eight inhibitor bypassing activity. Critical Care Medicine, 41(5), e42-e46. doi:10.1097/CCM.0b013e31827caaa3

  • Damle, R., Levine, J. H., Greenberg, S., Goldberger, J. J., & Kadish, A. H. (1991). An evaluation of the efficacy and safety of moricizine for inducible sustained ventricular arrhythmias. Clinical Research, 39(2), 346A. 

  • Damle, R., Levine, J., Matos, J., Greenberg, S., Brooks, R., Frumkin, W., . . . Kadish, A. H. (1992). Efficacy and risks of moricizine in inducible sustained ventricular tachycardia. Annals of Internal Medicine, 116(5), 375-381. doi:10.7326/0003-4819-116-5-375

  • Damle, R. S., Choe, W., Kanaan, N. M., Ehlert, F. A., Goldberger, J. J., & Kadish, A. H. (1994). Atrial and accessory pathway activation direction in patients with orthodromic supraventricular tachycardia: Insights from vector mapping. Journal of Investigative Medicine, 23(3), 684-92. doi:10.1016/0735-1097(94)90755-2

  • Damle, R. S., Goldberger, J. J., & Kadish, A. H. (1992). Spatial and temporal linking of epicardial activation directions during ventricular fibrillation in dogs. Evidence for underlying organization. Circulation, 86(5), 1547-1558. doi:10.1161/01.CIR.86.5.1547

  • Damle, R. S., Robinson, N. S., Ye, D. Z., Roth, S. I., Goldberger, J. J., & Kadish, A. H. (1995). Electrical activation during ventricular fibrillation in the subacute and chronic phases of healing canine myocardial infarction. Circulation, 92(3), 535-545. This material can be found here.

  • Daniels, B. H., McComb, R. D., Mobley, B. C., Gultekin, S. H., Lee, H. S., & Margeta, M. (2013). LC3 and p62 as diagnostic markers of drug-induced autophagic vacuolar cardiomyopathy: A study of 3 cases. American Journal of Surgical Pathology, 37(7), 1014-1021. doi:10.1097/PAS.0b013e3182863fa8

  • Duby, J. J., Heintz, S. J., Bajorek, S. A., Heintz, B. H., Durbin-Johnson, B. P., & Cocanour, C. S. (2017). Prevalence and course of atrial fibrillation in critically ill trauma patients. Journal of Intensive Care Medicine, 32(2), 140-145. doi:10.1177/0885066615599150

First Prev 1 2 3 4 5 6 7 8 9 10 Next Last